A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

More than 390 million children and adolescents were overweight or obese as of 2022, according to the World Health ...

Physician and economist Jay Bhattacharya has been selected by Donald Trump to lead the National Institutes of Health.

A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

For years, the mantra that skipping breakfast contributes to obesity has been ingrained in our minds. This idea implies that ...

Semaglutide, a GLP-1 agonist, has been widely studied due to its versatility, efficacy, and ability to address multiple ...

Food insecurity is a significant public health concern that disproportionately affects marginalized communities, contributing ...

Nearly half of adolescents and three-quarters of adults in the U.S. were classified as being clinically overweight or obese ...